ERBB2 and breast carcinoma: To confirm the interaction between the two receptors under endogenous expression levels in the context of breast cancer, we chose SKBR3 cells that, compared to other breast cancer cell lines, express higher levels of HER2 and intermediate/lower levels of RANK and do not express EGFR [43].